» Articles » PMID: 18713727

Interleukin-10 Inhibits Tumor Necrosis Factor-alpha Production in Lipopolysaccharide-stimulated RAW 264.7 Cells Through Reduced MyD88 Expression

Overview
Journal Innate Immun
Publisher Sage Publications
Date 2008 Aug 21
PMID 18713727
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of interleukin (IL)-10-mediated inhibition of tumor necrosis factor (TNF)-alpha production was studied by lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. IL-10 inhibited TNF-alpha production transiently at an early stage after LPS stimulation. IL-10 inhibited the activation of nuclear factor (NF)-kappaB, p38 and stress-activated protein kinase (SAPK) in LPS-stimulated RAW 264.7 cells. Although the level of MyD88 protein increased in response to LPS, IL-10 prevented the LPS-induced MyD88 augmentation. There was no significant difference in the MyD88 mRNA expression between the cells pretreated with or without IL-10 in response to LPS. Therefore, IL-10 was suggested to inhibit LPS-induced TNF-alpha production via reduced MyD88 expression.

Citing Articles

Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia.

Rafiei M, Shojaei A, Chau Y Drug Deliv. 2025; 32(1):2465909.

PMID: 40028722 PMC: 11878168. DOI: 10.1080/10717544.2025.2465909.


Decreased Hepatic and Serum Levels of IL-10 Concur with Increased Lobular Inflammation in Morbidly Obese Patients.

Solleiro-Villavicencio H, Mendez-Garcia L, Ocampo-Aguilera N, Baltazar-Perez I, Arreola-Miranda J, Aguayo-Guerrero J Medicina (Kaunas). 2024; 60(6).

PMID: 38929479 PMC: 11205754. DOI: 10.3390/medicina60060862.


Interleukin-10 signaling in somatosensory neurons controls CCL2 release and inflammatory response.

de Souza S, Rosario Claudio J, Sim J, Inyang K, Dagenais A, Monahan K Brain Behav Immun. 2023; 116:193-202.

PMID: 38081433 PMC: 10843623. DOI: 10.1016/j.bbi.2023.12.013.


Single-cell secretion analysis reveals a dual role for IL-10 in restraining and resolving the TLR4-induced inflammatory response.

Alexander A, Kelsey I, Forbes H, Miller-Jensen K Cell Rep. 2021; 36(12):109728.

PMID: 34551303 PMC: 8995750. DOI: 10.1016/j.celrep.2021.109728.


Dual delivery of IL-10 and AT-RvD1 from PEG hydrogels polarize immune cells towards pro-regenerative phenotypes.

Sok M, Baker N, McClain C, Lim H, Turner T, Hymel L Biomaterials. 2020; 268:120475.

PMID: 33321293 PMC: 11129952. DOI: 10.1016/j.biomaterials.2020.120475.